
[ Wed, Oct 23rd 2019 ]: WOPRAI
[ Wed, Oct 23rd 2019 ]: WOPRAI
[ Wed, Oct 23rd 2019 ]: WOPRAI
[ Wed, Oct 23rd 2019 ]: WOPRAI
[ Wed, Oct 23rd 2019 ]: WOPRAI
[ Wed, Oct 23rd 2019 ]: WOPRAI
[ Wed, Oct 23rd 2019 ]: WOPRAI
[ Wed, Oct 23rd 2019 ]: WOPRAI
[ Wed, Oct 23rd 2019 ]: WOPRAI
[ Wed, Oct 23rd 2019 ]: WOPRAI
[ Wed, Oct 23rd 2019 ]: WOPRAI
[ Wed, Oct 23rd 2019 ]: WOPRAI
[ Wed, Oct 23rd 2019 ]: WOPRAI

[ Tue, Oct 22nd 2019 ]: WOPRAI
[ Tue, Oct 22nd 2019 ]: WOPRAI
[ Tue, Oct 22nd 2019 ]: WOPRAI
[ Tue, Oct 22nd 2019 ]: WOPRAI
[ Tue, Oct 22nd 2019 ]: WOPRAI
[ Tue, Oct 22nd 2019 ]: WOPRAI
[ Tue, Oct 22nd 2019 ]: WOPRAI
[ Tue, Oct 22nd 2019 ]: WOPRAI
[ Tue, Oct 22nd 2019 ]: WOPRAI
[ Tue, Oct 22nd 2019 ]: WOPRAI
[ Tue, Oct 22nd 2019 ]: WOPRAI
[ Tue, Oct 22nd 2019 ]: WOPRAI
[ Tue, Oct 22nd 2019 ]: WOPRAI
[ Tue, Oct 22nd 2019 ]: WOPRAI
[ Tue, Oct 22nd 2019 ]: WOPRAI
[ Tue, Oct 22nd 2019 ]: WOPRAI
[ Tue, Oct 22nd 2019 ]: WOPRAI
[ Tue, Oct 22nd 2019 ]: WOPRAI
[ Tue, Oct 22nd 2019 ]: WOPRAI
[ Tue, Oct 22nd 2019 ]: WOPRAI
[ Tue, Oct 22nd 2019 ]: WOPRAI
[ Tue, Oct 22nd 2019 ]: WOPRAI

[ Mon, Oct 21st 2019 ]: WOPRAI
[ Mon, Oct 21st 2019 ]: WOPRAI
[ Mon, Oct 21st 2019 ]: WOPRAI
[ Mon, Oct 21st 2019 ]: WOPRAI
[ Mon, Oct 21st 2019 ]: WOPRAI
[ Mon, Oct 21st 2019 ]: WOPRAI
[ Mon, Oct 21st 2019 ]: WOPRAI
[ Mon, Oct 21st 2019 ]: WOPRAI
[ Mon, Oct 21st 2019 ]: WOPRAI
[ Mon, Oct 21st 2019 ]: WOPRAI
[ Mon, Oct 21st 2019 ]: WOPRAI
[ Mon, Oct 21st 2019 ]: WOPRAI
[ Mon, Oct 21st 2019 ]: WOPRAI
Robyn Karnauskas Maintained (VRTX) at Strong Buy with Increased Target to $225 on, Oct 22nd, 2019


🞛 This publication is a summary or evaluation of another publication
Robyn Karnauskas of Citigroup, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Strong Buy with Increased Target from $205 to $225 on, Oct 22nd, 2019.
Robyn has made no other calls on VRTX in the last 4 months.
There are 6 other peers that have a rating on VRTX. Out of the 6 peers that are also analyzing VRTX, 1 agrees with Robyn's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Alan Carr of "Needham" Downgraded from Strong Buy to Hold on, Thursday, August 1st, 2019
These are the ratings of the 5 analyists that currently disagree with Robyn
- Ying Huang of "B of A Securities" Initiated at Strong Buy and Held Target at $220 on, Thursday, October 17th, 2019
- Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $240 on, Friday, September 6th, 2019
- Paul Matteis of "Stifel" Maintained at Strong Buy with Increased Target to $211 on, Thursday, August 1st, 2019
- Edward Tenthoff of "Piper Sandler" Maintained at Buy with Increased Target to $230 on, Thursday, August 1st, 2019
- Evan Seigerman of "Credit Suisse" Maintained at Buy with Increased Target to $213 on, Thursday, August 1st, 2019
Similar Stocks and Investing Publications
[ Thu, Oct 17th 2019 ]: WOPRAI
[ Thu, Oct 17th 2019 ]: WOPRAI
[ Fri, Sep 06th 2019 ]: WOPRAI
[ Thu, Nov 09th 2017 ]: WOPRAI
[ Thu, Nov 09th 2017 ]: WOPRAI
[ Mon, Nov 06th 2017 ]: WOPRAI
[ Fri, Oct 27th 2017 ]: WOPRAI
[ Wed, Oct 25th 2017 ]: WOPRAI
[ Wed, Oct 25th 2017 ]: WOPRAI
[ Tue, Oct 24th 2017 ]: WOPRAI
[ Mon, Oct 23rd 2017 ]: WOPRAI
[ Wed, Oct 18th 2017 ]: WOPRAI